Arcturus Therapeutics Holdings Inc (ARCT)
R&D Expense Growth
-42.50%
Fiscal year · Period ending:
ARCT R&D Expense Growth
Latest reported-42.50%period ending
Latest reported-42.50%period ending
ARCT FY R&D Growth (YoY) (0.00% → -42.50%)
Latest values, visible window
High-resolution chart · PNG
ARCT r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -42.5014% | |
| 1.5734% | |
| 30.0384% | |
| -14.9683% | |
| 200.3838% | |
| 71.956% | |
| 98.0921% | |
| 6.6843% | |
| -13.4468% | |
| 36.6243% | |
| -46.3812% | |
| 255.293% | |
| 763.8142% | |
| -55.1043% | |
| 0% |